Patient education on the iPad

Article

Eyemaginations has launched an eye-care app, called LUMA Vision Simulator, for use on the iPad. The new app aims to help doctors present complex information on common eye diseases to their patients in an engaging, easy?to?understand manner

Baltimore-Eyemaginations has launched an eye-care app, called LUMA Vision Simulator, for use on the iPad. The new app aims to help doctors present complex information on common eye diseases to their patients in an engaging, easy‐to‐understand manner. It features on‐screen drawing functionality and gives the doctor the ability to markup images as well as view disease progressions and point‐of‐view scenes side‐by‐side on one screen.

Information on the iPad screen can be shared over Apple’s Airplay and projected on a television screen with AppleTV.

“We are thrilled to be releasing our first iPad app with such innovative technology as on‐screen drawing and multiple views,” said Jeff Peres, president and CEO of Eyemaginations. “From the feedback received from our clients, we learned that not only are more practices using these mobile platforms, but they are now demanding higher levels of functionality. The LUMA Vision Simulator meets this demand and we remain committed to releasing comparable apps showcasing the same level of innovation in the near future.”

All of the LUMA Eyecare Apps are available for download in iTunes. They are free to all

Eyemaginations LUMA clients and as a free demo for all others.

For more articles in this issue of InDispensable, click here.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.